… Though historically regarded as an inert energy store, adipose tissue is a complex endocrine
organ, which is increasingly implicated in the pathogenesis of inflammatory bowel disease (…

… The latest estimate of the prevalence of inflammatory bowel disease (IBD) in the United States
… the prevalence of all forms of IBD including ulcerative colitis (UC), Crohn’s disease (CD), …

… inflammation due to the battle of the immune system with the trespassing gut bacteria leads
to the rise of inflammatory bowel disease … and their link to the disease are still unclear, the …

… G Monteleone has filed a patent related to the treatment of inflammatory bowel diseases
with Smad7 antisense oligonucleotides and has served as an advisory board member for …

… characterized by transmural inflammation and by skip lesions. Accumulating evidence … that
inflammatory bowel disease results from an inappropriate inflammatory response to intestinal …

… JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for
multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol 2015; 310: G155–G162. …

… Inflammatory bowel disease (IBD) is a complex genetic disease that is instigated and
amplified by the confluence of multiple genetic and environmental variables that perturb the …

… of difference source of MSCs in treatment Inflammatory Bowel Disease. 4 Route of MSCs-based
therapy for IBDs … Table 3 MSC-based clinical trials for inflammatory bowel disease. …

… coincided with a worldwide increase in the incidence of inflammatory bowel disease (IBD)
in recent decades [2]. Consumption of a higher ratio of pro-inflammatory n-6 PUFAs, such as …

Inflammatory bowel diseases (IBD) arise from a convergence of genetic risk, environmental
factors, and gut microbiota, where each is necessary but not sufficient to cause …